Your browser version may not work well with NCBI's Web applications. More information here...
 Display Show
 Tools:             Links: Related Structures, BioAssays, Literature, Other Links  
Items 1 - 20 of 40908453
of 2045423Next
1: SID: 50130528Related Structures, Literature
N-nonyl-1-deoxynojirimycin; NCGC00182087-01
Compound ID: 501640
Source: NCGC (NCGC00182087-01)
IUPAC: (2R,3R,4R,5S)-2-(hydroxymethyl)-1-nonylpiperidine-3,4,5-triol
MW: 289.410940 g/mol | MF: C15H31NO4
2: SID: 50130527Related Structures
Compound ID: 24875296
Source: Thomson Pharma (02630113)
IUPAC: N-​(2-​hydroxyethyl)-​5-​[4-​methoxy-​3-​[2-​oxo-​2-​[4-​(1-​phenyltetrazol-​5-​yl)piperazin-​1-​yl]acetyl]-​1H-​pyrrolo[2,3-​c]pyridin-​7-​yl]-​2H-​pyrazole-​3-​carboxamide
MW: 585.573980 g/mol | MF: C27H27N11O5
3: SID: 50130526Related Structures
Compound ID: 24875295
Source: Thomson Pharma (02630112)
IUPAC: 1-​(4-​hydroxy-​7-​pyrazol-​1-​yl-​1H-​pyrrolo[5,4-​c]pyridin-​3-​yl)-​2-​[4-​(4-​phenyl-​1,2,4-​triazol-​3-​yl)piperazin-​1-​yl]ethane-​1,2-​dione
MW: 483.482040 g/mol | MF: C24H21N9O3
4: SID: 50130525Related Structures
Compound ID: 24875294
Source: Thomson Pharma (02630111)
IUPAC: 1-​[7-​(5-​aminopyrazol-​1-​yl)-​4-​fluoro-​1H-​pyrrolo[5,4-​c]pyridin-​3-​yl]-​2-​[4-​(1-​phenyltetrazol-​5-​yl)piperazin-​1-​yl]ethane-​1,2-​dione
MW: 501.475803 g/mol | MF: C23H20FN11O2
5: SID: 50130524Related Structures
Compound ID: 24875293
Source: Thomson Pharma (02630110)
IUPAC: 1-​[7-​(3-​aminopyrazol-​1-​yl)-​4-​fluoro-​1H-​pyrrolo[5,4-​c]pyridin-​3-​yl]-​2-​[4-​(1-​phenyltetrazol-​5-​yl)piperazin-​1-​yl]ethane-​1,2-​dione
MW: 501.475803 g/mol | MF: C23H20FN11O2
6: SID: 50130523Related Structures
Compound ID: 24875292
Source: Thomson Pharma (02630109)
IUPAC: 1-​[4-​fluoro-​7-​(5-​methylpyrazol-​1-​yl)-​1H-​pyrrolo[5,4-​c]pyridin-​3-​yl]-​2-​[4-​(1-​phenyltetrazol-​5-​yl)piperazin-​1-​yl]ethane-​1,2-​dione
MW: 500.487743 g/mol | MF: C24H21FN10O2
7: SID: 50130522Related Structures
Compound ID: 24875291
Source: Thomson Pharma (02630033)
IUPAC: 3,3,3-​trifluoro-​2-​methyl-​N-​[(2R)-​1-​oxo-​1-​[[(3R)-​2-​oxo-​1-​propan-​2-​yl-​4,5-​dihydro-​3H-​1-​benzazepin-​3-​yl]amino]-​3-​[2-​(trifluoromethoxy)phenyl]propan-​2-​yl]-​2-​(trifluoromethyl)propanamide
MW: 641.525249 g/mol | MF: C28H28F9N3O4
8: SID: 50130521Related Structures
Compound ID: 24875290
Source: Thomson Pharma (02630032)
IUPAC: N-​[(2R)-​1-​oxo-​1-​[[(3R)-​2-​oxo-​1-​propan-​2-​yl-​4,5-​dihydro-​3H-​1-​benzazepin-​3-​yl]amino]-​3-​[2-​(trifluoromethoxy)phenyl]propan-​2-​yl]-​2-​(trifluoromethoxy)benzamide
MW: 637.569479 g/mol | MF: C31H29F6N3O5
9: SID: 50130520Related Structures
Compound ID: 24875289
Source: Thomson Pharma (02630031)
IUPAC: 2-​bromo-​N-​[(2R)-​1-​oxo-​1-​[[(3R)-​2-​oxo-​1-​propan-​2-​yl-​4,5-​dihydro-​3H-​1-​benzazepin-​3-​yl]amino]-​3-​[2-​(trifluoromethoxy)phenyl]propan-​2-​yl]benzamide
MW: 632.468170 g/mol | MF: C30H29BrF3N3O4
10: SID: 50130519Related Structures
Compound ID: 24875288
Source: Thomson Pharma (02630030)
IUPAC: 4-​fluoro-​N-​[(2R)-​1-​oxo-​1-​[[(3R)-​2-​oxo-​1-​propan-​2-​yl-​4,5-​dihydro-​3H-​1-​benzazepin-​3-​yl]amino]-​3-​[2-​(trifluoromethoxy)phenyl]propan-​2-​yl]-​2-​(trifluoromethyl)benzamide
MW: 639.560542 g/mol | MF: C31H28F7N3O4
11: SID: 50130518Related Structures
Compound ID: 24875287
Source: Thomson Pharma (02629945)
IUPAC: 3-(piperidine-1-carbonyl)-1H-pyrazolo[1,5-a]quinazolin-5-one
MW: 296.323840 g/mol | MF: C16H16N4O2
12: SID: 50130517Related Structures
Compound ID: 24875286
Source: Thomson Pharma (02629944)
IUPAC: N,N-dimethyl-5-oxo-1H-pyrazolo[1,5-a]quinazoline-3-carboxamide
MW: 256.259980 g/mol | MF: C13H12N4O2
13: SID: 50130516Related Structures
Compound ID: 24875285
Source: Thomson Pharma (02629943)
IUPAC: 3-(pyrrolidine-1-carbonyl)-1H-pyrazolo[1,5-a]quinazolin-5-one
MW: 282.297260 g/mol | MF: C15H14N4O2
14: SID: 50130515Related Structures
Compound ID: 24875284
Source: Thomson Pharma (02629942)
IUPAC: 3-(4-methylpiperazine-1-carbonyl)-1H-pyrazolo[1,5-a]quinazolin-5-one
MW: 311.338480 g/mol | MF: C16H17N5O2
15: SID: 50130514Related Structures
Compound ID: 24875283
Source: Thomson Pharma (02629941)
IUPAC: methyl 3-[(5-oxo-1H-pyrazolo[1,5-a]quinazolin-2-yl)methyl]benzoate
MW: 333.340700 g/mol | MF: C19H15N3O3
16: SID: 50130513Related Structures
Compound ID: 24875282
Source: Thomson Pharma (02629940)
IUPAC: 2-[[3-(2-fluoropyridin-4-yl)phenyl]methyl]-1H-pyrazolo[1,5-a]quinazolin-5-one
MW: 370.379103 g/mol | MF: C22H15FN4O
17: SID: 50130512Related Structures
Compound ID: 24875281
Source: Thomson Pharma (02629939)
IUPAC: 2-[3-[(5-oxo-1H-pyrazolo[1,5-a]quinazolin-2-yl)methyl]phenyl]benzaldehyde
MW: 379.410680 g/mol | MF: C24H17N3O2
18: SID: 50130511Related Structures
Compound ID: 24875280
Source: Thomson Pharma (02629836)
IUPAC: 5-fluoro-3-(4-methoxyphenyl)-3-(3-pyrimidin-5-ylphenyl)isoindol-1-amine
MW: 410.442963 g/mol | MF: C25H19FN4O
19: SID: 50130510Related Structures
Compound ID: 24875278
Source: Thomson Pharma (02629835)
IUPAC: acetic acid; 5-[3-(3-amino-1-pyridin-4-ylisoindol-1-yl)phenyl]pyridine-3-carbonitrile
MW: 447.487940 g/mol | MF: C27H21N5O2
20: SID: 50130509Related Structures
Compound ID: 24875277
Source: Thomson Pharma (02629834)
IUPAC: 3-[3-(2-fluoropyridin-3-yl)phenyl]-3-[4-(trifluoromethyl)phenyl]isoindol-1-amine
MW: 447.426893 g/mol | MF: C26H17F4N3
Items 1 - 20 of 40908453
of 2045423Next
 Display Show
 Tools:             Links: Related Structures, BioAssays, Literature, Other Links